Why The Chemours Company’s (CC) Stock Is Up 5.09%
As of Wednesday, August 19, The Chemours Company’s CC share price has surged by 5.09%, which has investors questioning if this is right time to sell.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
Commentary & Analysis
Why The Chemours Company’s (CC) Stock Is Down 5.27%
As of Monday, August 10, The Chemours Company’s CC share price has dipped by 5.27%, which has investors questioning if this is right time to buy.Jenna Brashear
Why The Chemours Company’s (CC) Stock Is Up 5.16%
As of Friday, August 07, The Chemours Company’s CC share price has surged by 5.16%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why The Chemours Company’s (CC) Stock Is Down 15.84%
As of Wednesday, August 05, The Chemours Company’s CC share price has dipped by 15.84%, which has investors questioning if this is right time to buy.Michael Rose
Is The Chemours Company (CC) Overvalued?
We dive into why The Chemours Company (CC) could be considered overvalued on 2026-08-04, based on AAII’s Value Score and Grade.Tudor Pop
Financial Summary
| Share Statistics | CC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,361.3 | $4,010.9 | 56% |
|
| Shares Out (Mil) | 151.2 | 92.2 | 71% |
|
| Institutional Ownership | 99.4% | 82.8% | 88% |
|
| Float (Mil) | 149.6 | 117.6 | 69% |
|
| Beta | 1.43 | 0.78 | 81% |
|
| Avg Daily Volume (000s) | 2,813 | 136 | 86% |
|
| Price Change (52-week) |
4.4% | 84.6% | 48% |
|
| Growth | CC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 3.2% | 4.0% | 28% |
|
| Net Income (5yr) | (30.3%) | (0.2%) | 13% |
|
| EPS (5yr) | (31.6%) | 1.5% | 8 |
|
| Dividends (5yr) | (12.5%) | 0.0% | 66% |
|
| Cash Flow (5yr) | (17.8%) | (15.3%) | 39% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 8 | 8 | 9 | |
| Current EPS | $0.268 | $0.985 | $1.928 | |
| Month Ago EPS | $0.537 | $1.281 | $2.240 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 3 | |
| Three Months Ago EPS | $0.557 | $1.298 | $2.261 | |
| Year/Year Chg | (114.8%) | (138.3%) | (190.9%) | |
| Financials | CC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $5,797 | $4,298 | 77% |
|
| Net Income (TTM) (Mil) | ($304) | $58 | 5% |
|
| EPS (TTM) | ($2.017) | $0.300 | 14% |
|
| Operating Cash Flow (TTM) (Mil) | $397 | $446 | 68% |
|
| Net Cash Flow (TTM) (Mil) | $170 | $4 | 82% |
|
| Long-Term Debt (Q1) (Mil) | $4,029 | $1,795 | 83% |
|
| Enterprise Value (Q1) (Mil) | $5,647 | $5,576 | 64% |
|
| Valuation | CC | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.60 | na |
|
| P/E | na | 25.4 | na |
|
| Dividend Yield | 2.2% | 1.2% | 78% |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | CC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 15.4% | 27.5% | 15% |
|
| Net Margin | (5.2%) | 3.0% | 25% |
|
| ROA | (4.2%) | 1.5% | 31% |
|
| ROE | (323.4%) | 3.9% | 2% |
|
| Liabilities to Assets | 100.7% | 54.0% | 94% |
|
| F-Score | 5 | 5 | 50% |
|
Passing Stock Screens
As of 8/20/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Est Rev: Lowest 30 Down
Factors: Earnings Estimates
Introduction to the use of earnings estimates.
| Performance Since Inception: | 2.9% |
| +/- S&P 500: | -4.6 |
FACTOR STRATEGY
Est Rev: Down 5% Screen
Factors: Earnings Estimates
Introduction to the use of earnings estimates.
| Performance Since Inception: | 2.4% |
| +/- S&P 500: | -5.1 |
